Regen BioPharma Inc (RGBP)

[Jack Torrance]

My experience with OTC biopharma tickers is that Regen is behaving totally typically. Lots of ups and downs. Until a company is earning revenue on a quarterly basis, with consistency, they will be catalyst driven. With a catalyst you see a short-term pop, like we have seen with going current and the patent approvals. But when there are no catalysts, the share price bleeds down. Yes, their patents are very valuable. But at the current moment, that is all they are: patents. A patent is a protection of an idea, or intellectual property. It is not a product ready for sale. To bring their IP to market, they first have to design a specific medication to treat a specific thing and then perform clinical trials, which can take 4-10 years and cost up to $150 million dollars. And when it comes to an injectible cancer drug to reduce tumors, it will likely be the most lengthy and costly clinical trials you can imagine, because the drug regimen will be lots of injections and then lots of MRI's and imaging scans and blood analysis over many months FOR EACH CLINICAL SUBJECT.

It's for those reasons that I want a buyout. I don't want to wait years and years for the chance that MAYBE they find success. I just want a larger pharma company to buy them for at LEAST $10 billion. Hopefully more like $25-$40 billion.

And if you hadn't noticed, we are in a bear market right now. We are 18 months into a global pandemic and now a Chinese debt crisis looms. Crazy how many people forget this.